BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota

    NEXT STORY
    Y-mAbs Signs License Agreement with SciClone for DANYELZA® (naxitamab-gqgk) and Omburtamab in China
    PREV STORY
    Bavarian Nordic Announces Top-line Results from Phase 2 Clinical Trial of BN-Brachyury in Chordoma
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progress Despite Adjusted Operations Due to COVID-19

    author_avatar
    NASDAQ Market News

    RedHill Biopharma Reports Second Quarter 2019 Financial Results and Operational Highlights

    author_avatar
    NASDAQ Market News

    Project HOPE Deploys Medical Team After Maria Slams Puerto Rico

    Millwood, VA, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Project HOPE announced the deployment of ...

    author_avatar
    NASDAQ Market News